Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
It promotes actin sequestration and is studied for accelerating wound healing, reducing fibrosis, and improving function after ischemic or traumatic injuries
Performance optimization Improving energy production and recovery capacity
Theres insufficient human evidence
Based on published evidence, semaglutide is the far more effective choice for fat loss, and AOD-9604 is now FDA-restricted (Category 2 bulk drug substance) for US compounding
choice depends on which vitamins youre lacking and clinical goals
Research Note: Published preclinical research, including a 2025 literature and patent review in the journal Pharmaceuticals (Jzwiak et al., 2025, Pharmaceuticals ), has documented BPC-157's effects on angiogenesis, nitric oxide signaling, and tissue protection in animal models, though authors note that no completed human clinical trials have been published to confirm these effects in people
